切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - S-nitrosoglutathione reductase - CETP - Insulin and Insulin-like Receptors - Thymidylate Synthase

11件产品中的 1-10

页面
每页
清除全部
  1. Raltitrexed
    B1476 Raltitrexed
    中文名: 雷替曲塞
    Target: Thymidylate Synthase
    Summary: 胸苷酸合酶抑制剂
      ≥154 mg/mL
      insoluble in H2O
  2. N6022
    B1111 N6022
    Target: S-nitrosoglutathione reductase
    Summary: GSNOR抑制剂
      ≥20.7 mg/mL
      insoluble in H2O
  3. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  4. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  5. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  6. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O
  7. Pemetrexed
    A4390 Pemetrexed
     1 Citation
    中文名: 培美曲塞二钠盐
    Target: Thymidylate Synthase|DHFR|GARFT
    Summary: TS、DHFR、GARFT和AICARFT抑制剂
      ≥15.68 mg/mL
      ≥30.67 mg/mL
  8. Evacetrapib (LY2484595)
    A4377 Evacetrapib (LY2484595)
    Target: CETP
    Summary: 强效的CETP选择性抑制剂
      ≥32.1 mg/mL
      insoluble in H2O
  9. Anacetrapib (MK-0859)
    A4375 Anacetrapib (MK-0859)
     1 Citation
    中文名: 安塞曲匹
    Target: CETP
    Summary: RhCETP/突变型 CETP(C13S) 抑制剂
      ≥31.9 mg/mL
      insoluble in H2O
  10. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    中文名: 马来酸罗格列酮
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ激动剂,有效的胰岛素敏化剂
      ≥23.7 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页